E. Arffmann

473 total citations
28 papers, 276 citations indexed

About

E. Arffmann is a scholar working on Epidemiology, Cancer Research and Molecular Biology. According to data from OpenAlex, E. Arffmann has authored 28 papers receiving a total of 276 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 4 papers in Cancer Research and 3 papers in Molecular Biology. Recurrent topics in E. Arffmann's work include Cervical Cancer and HPV Research (6 papers), Cancer, Lipids, and Metabolism (4 papers) and Endometrial and Cervical Cancer Treatments (2 papers). E. Arffmann is often cited by papers focused on Cervical Cancer and HPV Research (6 papers), Cancer, Lipids, and Metabolism (4 papers) and Endometrial and Cervical Cancer Treatments (2 papers). E. Arffmann collaborates with scholars based in Denmark, France and Finland. E. Arffmann's co-authors include Erik Soegaard Andersen, J. Glavind, P. Stubbe Teglbjærg, Preben Johansen, J Laustsen, Elsebeth Lynge, K. Kock, Gorm Pallesen, Niels Hjørne and P Poll and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, British Journal of Cancer and Cellular and Molecular Life Sciences.

In The Last Decade

E. Arffmann

28 papers receiving 243 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Arffmann Denmark 9 112 75 52 42 35 28 276
George L. Phillips United States 11 116 1.0× 64 0.9× 12 0.2× 64 1.5× 66 1.9× 24 403
George S. Loquvam United States 8 21 0.2× 10 0.1× 64 1.2× 65 1.5× 45 1.3× 11 367
Ioannis Boutas Greece 10 30 0.3× 71 0.9× 22 0.4× 29 0.7× 43 1.2× 43 296
Thomas E. Rohan United States 9 90 0.8× 27 0.4× 109 2.1× 25 0.6× 74 2.1× 10 549
Ezzat Mahboubi Saudi Arabia 10 47 0.4× 16 0.2× 56 1.1× 223 5.3× 62 1.8× 12 486
Patti Olusola United States 4 119 1.1× 35 0.5× 84 1.6× 31 0.7× 134 3.8× 4 296
Jafaru Abu United Kingdom 11 50 0.4× 134 1.8× 50 1.0× 48 1.1× 119 3.4× 22 460
Dilek Bülbül Türkiye 12 42 0.4× 144 1.9× 32 0.6× 34 0.8× 59 1.7× 19 347
Francesca Sanseverino Italy 10 55 0.5× 63 0.8× 36 0.7× 30 0.7× 95 2.7× 19 321
Nicholas Titiloye Ghana 8 49 0.4× 10 0.1× 51 1.0× 23 0.5× 34 1.0× 23 306

Countries citing papers authored by E. Arffmann

Since Specialization
Citations

This map shows the geographic impact of E. Arffmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Arffmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Arffmann more than expected).

Fields of papers citing papers by E. Arffmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Arffmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Arffmann. The network helps show where E. Arffmann may publish in the future.

Co-authorship network of co-authors of E. Arffmann

This figure shows the co-authorship network connecting the top 25 collaborators of E. Arffmann. A scholar is included among the top collaborators of E. Arffmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Arffmann. E. Arffmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lynge, Elsebeth, E. Arffmann, A Glenthøj, et al.. (1996). [Preventive examinations for cervix cancer in Denmark. Status in 1995. Plans for 1996].. PubMed. 158(35). 4916–9. 4 indexed citations
2.
Lynge, Elsebeth, et al.. (1994). [Status of preventive screening for uterine cervix cancer in Denmark in 1994].. PubMed. 156(4). 471–3. 4 indexed citations
3.
Lynge, Elsebeth, et al.. (1993). Smear misclassification in a cervical cancer screening programme. British Journal of Cancer. 68(2). 368–373. 8 indexed citations
4.
Andersen, Erik Soegaard & E. Arffmann. (1989). Adenocarcinoma in situ of the uterine cervix: A clinico-pathologic study of 36 cases. Gynecologic Oncology. 35(1). 1–7. 89 indexed citations
5.
Glenthøj, Andreas, et al.. (1983). Skin carcinogenesis in rats by 3-methylcholanthrene and 7,12-dimethylbenz(alpha)anthracene. Influence of dose and frequency on tumour response and its histological type.. PubMed. 91(6). 445–55. 4 indexed citations
6.
Arffmann, E., et al.. (1981). Effect of some fatty acid methyl esters on gastrointestinal carcinogenesis by N-methyl-N-nitro-N-nitrosoguanidine in rats.. PubMed. 67(5). 1071–5. 2 indexed citations
7.
Arffmann, E. & Niels Hjørne. (1979). INFLUENCE OF SURFACE LIPIDS ON SKIN CARCINOGENESIS IN RATS. Acta Pathologica Microbiologica Scandinavica Section A Pathology. 87A(1-6). 143–149. 4 indexed citations
8.
Johansen, Preben, E. Arffmann, & Gorm Pallesen. (1979). Evaluation of smears obtained by cervical scraping and an endocervical swab in the diagnosis of neoplastic disease of the uterine cervix. Acta Obstetricia Et Gynecologica Scandinavica. 58(3). 265–270. 9 indexed citations
9.
Arffmann, E., et al.. (1976). [Vaginal pipette and cervical smear. Comparison of their diagnostic reliability in screening].. PubMed. 138(17). 1021–5. 1 indexed citations
10.
Glavind, J., et al.. (1975). CARCINOGENICITY IN MICE OF SOME FATTY ACID METHYL ESTERS.. Acta Pathologica Microbiologica Scandinavica Section A Pathology. 83A(5). 550–558. 6 indexed citations
11.
Arffmann, E. & J. Glavind. (1974). CARCINOGENICITY IN MICE OF SOME FATTY ACID METHYL ESTERS. Acta Pathologica Microbiologica Scandinavica Section A Pathology. 82A(1). 127–136. 4 indexed citations
12.
Arffmann, E. & J. Glavind. (1970). Toxicity of fatty acid derivatives in the newt test and its influence on the specific response.. PubMed. 212. Suppl 212:97+–Suppl 212:97+. 3 indexed citations
13.
Glavind, J. & E. Arffmann. (1970). THE POSSIBLE CARCINOGENIC PROPERTIES OF ALTERED LIPIDS. Acta Pathologica Microbiologica Scandinavica Section A Pathology. 78A(3). 345–350. 6 indexed citations
14.
Glavind, J. & E. Arffmann. (1968). Studies by the newt test on the possible importance of conjugated double-bonds and trans-isomerization for carcinogenic properties of lipids. Cellular and Molecular Life Sciences. 24(8). 829–830. 5 indexed citations
15.
Arffmann, E. & J. Glavind. (1967). STUDIES BY THE NEWT TEST ON CARCINOGENIC PROPERTIES OF FATS. Acta Pathologica Microbiologica Scandinavica. 70(2). 185–195. 6 indexed citations
16.
Arffmann, E., et al.. (1965). Squamous carcinoma of the breast: Report of a case. The Journal of Pathology and Bacteriology. 90(1). 319–320. 19 indexed citations
17.
Arffmann, E.. (1964). HEATED FATS AND ALLIED COMPOUNDS AS CARCINOGENS. Acta Pathologica Microbiologica Scandinavica. 61(2). 161–180. 11 indexed citations
18.
Arffmann, E.. (1963). STUDIES ON THE NEWT TEST FOR CARCINOGENICITY. Acta Pathologica Microbiologica Scandinavica. 57(4). 375–394. 6 indexed citations
19.
Arffmann, E.. (1962). STUDIES ON THE NEWT TEST FOR CARCINOGENICITY. Acta Pathologica Microbiologica Scandinavica. 55(3). 281–288. 8 indexed citations
20.
Arffmann, E., et al.. (1961). STUDIES ON THE NEWT TEST FOR CARCINOGENICITY. Acta Pathologica Microbiologica Scandinavica. 52(4). 330–342. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by George L. Phillips Breakdown of academic impact, for papers by George S. Loquvam Breakdown of academic impact, for papers by Ioannis Boutas Breakdown of academic impact, for papers by Thomas E. Rohan Breakdown of academic impact, for papers by Ezzat Mahboubi Breakdown of academic impact, for papers by Patti Olusola Breakdown of academic impact, for papers by Jafaru Abu Breakdown of academic impact, for papers by Dilek Bülbül Breakdown of academic impact, for papers by Francesca Sanseverino Breakdown of academic impact, for papers by Nicholas Titiloye
Rankless by CCL
2026